EPA Revises List of Disinfectants for Combating Bloodborne Pathogens

The EPA’s newly released list combines product information from former disinfectant lists.

February 29, 2024

The U.S. Environmental Protection Agency (EPA) has combined and updated information from several disinfectant lists to create a new list titled EPA-Registered Antimicrobial Products Effective Against Bloodborne Pathogens (HIV, Hepatitis B, and Hepatitis C) [List S].

The EPA’s newly released list combines product information from the agency’s following former disinfectant lists: 

  • List C: EPA’s Registered Antimicrobial Products Effective Against Human HIV-1 Virus
  • List D: EPA’s Registered Antimicrobial Products Effective Against Human HIV-1 and Hepatitis B Virus
  • List E: EPA’s Registered Antimicrobial Products Effective Against Mycobacterium tuberculosis, Human HIV-1, and Hepatitis B Virus
  • List F: EPA’s Registered Disinfectants for use Against Hepatitis C.

These four lists are now retired and will be redirected to the new List S. Not only does the revised list includes products that are effective against HIV, Hepatitis B, and Hepatitis C, but it also specifies which products are not effective against one or more of these viruses.

For more information and to view the complete list of products, visit the EPA’s website.

Latest Articles

Dave Kahle
January 8, 2026 Jeff Cross

When Sales Breaks Down From the Inside

January 7, 2026 Sponsored by Tru-D

Inside Tru-D SmartUVC: The Importance of Service and Upkeep for UVC Disinfection

January 7, 2026 Sponsored by PDI

One Wipe. One Minute. One Solution. PDI Raises the Standard for Infection Prevention

Sponsored Articles

Tru-D Care
January 7, 2026 Sponsored by Tru-D

Inside Tru-D SmartUVC: The Importance of Service and Upkeep for UVC Disinfection

January 7, 2026 Sponsored by PDI

One Wipe. One Minute. One Solution. PDI Raises the Standard for Infection Prevention

December 15, 2025 Sponsored by Novonesis

Inside the Art of Cleaning—and What Happens When It Fails

Recent News

Blood test tube with measles results

First Measles Cases of 2026 Show Continuation of Outbreaks

Judge Denies HHS Effort to Dismiss Vaccine Policy Lawsuit

US Flu Cases Hit Highest Level in 25 Years